Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosus
Panagiotis Garantziotis(Universitätsklinikum Erlangen), Ioannis Parodis(Karolinska University Hospital), Andreas Wirsching(Universitätsklinikum Erlangen), Christina Bergmann(Friedrich-Alexander-Universität Erlangen-Nürnberg), Dimitrios T. Boumpas(National and Kapodistrian University of Athens), George Βertsias(University Hospital of Heraklion), Dionysis Nikolopoulos(Karolinska University Hospital), Georgia-Savina Moysidou(National and Kapodistrian University of Athens), Melanie Hagen(James Madison University), Guillermo Barturen(Universidad de Granada), Marta E. Alarcón‐Riquelme(Karolinska Institutet), Ricardo Grieshaber‐Bouyer(Heidelberg University), Aline Bözec(Center for Rheumatology), Georg Schett(Karolinska University Hospital), Andréas Mackensen(University Medical Center Freiburg), Lorenzo Beretta(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Matthias Schneider(Düsseldorf University Hospital), Julius Lindblom(Karolinska University Hospital)
Cited by 16
Related Papers
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
|Annals of the Rheumatic Diseases|2019|2k
Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
|Annals of the Rheumatic Diseases|2012|1k
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
|Annals of the Rheumatic Diseases|2014|726
Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin
|Journal of Clinical Investigation|2012|708